Pfizer Inc. Files Proxy Materials

TL;DR

Pfizer filed proxy docs, vote your shares!

AI Summary

Pfizer Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on April 11, 2025. The filing is related to the company's solicitation of proxies for its upcoming shareholder meeting. The document indicates that no filing fee was required, or it was previously paid.

Why It Matters

This filing is a standard procedural step for public companies to communicate with shareholders regarding voting matters, ensuring transparency and shareholder participation in corporate governance.

Risk Assessment

Risk Level: low — This is a routine proxy filing and does not contain new financial information or significant corporate actions that would inherently increase risk.

Key Players & Entities

• Pfizer Inc. (company) — Registrant
• Margaret M. Madden (person) — Contact Person

FAQ

From the Filing

0000078003-25-000102.txt : 20250411 0000078003-25-000102.hdr.sgml : 20250411 20250411100954 ACCESSION NUMBER: 0000078003-25-000102 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250411 DATE AS OF CHANGE: 20250411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PFIZER INC CENTRAL INDEX KEY: 0000078003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 135315170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-03619 FILM NUMBER: 25830331 BUSINESS ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 BUSINESS PHONE: 2127332323 MAIL ADDRESS: STREET 1: 66 HUDSON BOULEVARD EAST CITY: NEW YORK STATE: NY ZIP: 10001-2192 FORMER COMPANY: FORMER CONFORMED NAME: PFIZER CHARLES & CO INC DATE OF NAME CHANGE: 19710908 DEFA14A 1 supplemental041125.htm DEFA14A Supplemental 04.11.25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party Other Than the Registrant ¨ Check the Appropriate Box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to §240.14a-12 Pfizer Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of filing fee (Check all boxes that apply): x No fee required ¨ Fee paid previously with preliminary materials ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Margaret M. Madden Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001 YOUR VOTE IS IMPORTANT - PLEASE VOTE YOUR SHARES TODAY Dear Fellow Pfizer Shareholder: On April 24, 2025, Pfizer will hold its Annual Meeting of Shareholders. We value your input as a holder of Pfizer common stock and encourage you to review our proxy materials and cast your vote today. You can view our proxy materials at https://investors.pfizer.com/proxy. For the reasons set forth in the 2025 Proxy Statement, the Board of Directors recommends that you vote:  “FOR” each Director nominee.  “FOR” the ratification of the selection of KPMG LLP as Pfizer’s independent registered public accounting firm for 2025.  ‘’FOR” the 2025 advisory approval of executive compensation.  “AGAINST” the two shareholder proposals. The 2025 Annual Meeting will be held virtually. Please view our 2025 Proxy Statement for details on how you can participate. I encourage you to vote in advance of the Annual Meeting by using one of the methods described in the proxy materials. For your convenience, a duplicate proxy/voting instruction card and return envelope are enclosed, along with telephone and Internet voting instructions. Please note, if multiple proxies/voting instruction cards are received from you, the one with the latest date will be counted. Your vote is important. Ensure your shares are voted by acting today. Sincerely, Margaret M. Madden Senior Vice President and Corporate Secretary, Chief Governance Counsel GRAPHIC 2 supplemental041125votelt001.jpg begin 644 supplemental041125votelt001.jpg M_]C_X 02D9)1@ ! @ 0 ! #_VP!# @&!@ 7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@ 'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q ;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH